Researchers are increasingly intrigued by the prospect of using ivermectin, a drug normally used to treat parasitic worms, as a way of controlling mosquito populations to drive down malaria rates, according to news reports.
Regina Rabinovich, ExxonMobil Malaria Scholar in Residence at Harvard T.H. Chan School of Public Health, recently co-authored a guide to help researchers who are interested in studying ivermectin as a novel approach to thwarting the spread of malaria, according to a January 22, 2019 article in the Global Health News Wire.
“The results of several studies and recent trials have positioned ivermectin as a first-in-class drug to enhance malaria vector control,” Rabinovich said.
Read the Global Health News Wire article: A roadmap for adding ivermectin to the malaria toolbox